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Abstract
Objective: Anabolic-androgenic steroids (AAS) are nominated for 
clinical use to promote protein synthesis in many therapeutic condi-
tions. However, the indiscriminate use of AAS is related to hazardous 
cardiac disturbances and oxidative stress. We designed a study to in-
vestigate whether prolonged treatment with high doses of stanozo-
lol modifies the activities of some antioxidant enzymes in the heart in 
sedentary and trained rats and whether this treatment causes altera-
tions of cardiovascular parameters. In addition, the effectiveness of 
melatonin as an antioxidant and as a modulator of the cardiovascular 
side effects of stanozolol (STA) treatment was analyzed.
Materials and Methods: Thirty male Wistar rats were divided into the 
following six groups: sedentary (S), stanozolol sedentary (SS), stano-
zolol-melatonin sedentary (SMS), trained (T), stanozolol trained (ST) 
and stanozolol-melatonin trained (SMT). The stanozolol-treatment rats 
received 5 mg.kg-1 by subcutaneous injection before each exercise ses-
sion (5 d.wk-1, i.e., 25 mg.kg-1.wk-1), while control groups received only 
saline solution injection. The melatonin-treatment groups received 
intraperitoneal injections of melatonin (10 mg.kg-1), 5 d.wk-1 for 6 wk. 
Electrocardiography, blood pressure and antioxidant enzyme activity 
measurements were performed at the end of the experimental period 
for cardiac function and molecular assessment. 
Results: This is the first time that the in vivo effects of melatonin treat-
ment on stanozolol-induced cardiovascular side effects have been 
studied. Stanozolol induced bradycardia and significantly increased 
cardiac superoxide dismutase and catalase activities. Trained stanozo-
lol-treated rats experienced an increase in blood pressure and relative 
heart weight, and they developed left cardiac axis deviation. Although 
melatonin did not prevent cardiac hypertrophy in exercised stanozolol-
treated animals, it maintained blood pressure and cardiac catalase activ-
ity, and it prevented stanozolol-induced cardiac electrical axis deviation. 
Conclusion: In conclusion, under our experimental conditions, chronic 
stanozolol administration induced mild cardiovascular side effects that 
were partly attenuated by melatonin treatment. However, these results 
showed that the combination of melatonin and exercise could mini-
mize the stanozolol side effects in the cardiovascular system. 
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Özet
Amaç: Anabolik-androjenik steroidler (AAS) bir çok tedavi koşullarında 
protein sentezini artırmak üzere klinik kullanıma aday gösterilmektedir. 
Ancak, AAS’in gelişigüzel kullanımı tehlikeli kalp bozuklukları ve oksida-
tif stres ile ilişkilendirilmiştir. Bu çalışma, sedanter ve antrenmanlı sıçan-
larda stanozololun yüksek dozda uzun süreli kullanımının kalpte bazı an-
tioksidan enzim faaliyetleri değiştirip değiştirmediğini ve bu tedavinin 
kardiyovasküler parametrelerde değişikliklere neden olup olmayacağını 
araştırmak için tasarlanmıştır. Buna ek olarak, bir antioksidan ve stanozo-
lol (STA) tedavisinin kardiyovasküler yan etkilerinin bir modülatörü olan 
melatoninin etkinliği analiz edilmiştir.
Gereç ve Yöntem: Otuz erkek Wistar sıçan aşağıdaki altı gruba ayrılmış-
tır; sedanter (S), stanozolol sedanter (SS), stanozolol-melatonin sedanter 
(SMS), antrenmanlı(T), stanozolol- antrenmanlı (ST) ve stanozolol-mela-
tonin antrenmanlı (SMT). Stanozolol ile muamele edilen sıçanlar her eg-
zersiz seansından önce cilt altı enjeksiyonu ile 5 mg.kg-1 (5 d.wk-1, yani 25 
mg.kg-1.wk-1) stanozolol alırken, kontrol grubuna sadece serum fizyolojik 
enjeksiyonu yapılmıştır. Melatonin grupları için intraperitonal enjeksiyon 
ile 5 d.wk-1 (10 mg.kg-1) melatonin 6 hafta uygulanmıştır. Kalp fonksiyonu 
ve moleküler değerlendirilme amacıyla EKG, kan basıncı ve antioksidan 
enzim aktivite ölçümleri deney sürecinin sonunda yapılmıştır.
Bulgular: Bu çalışma ile ilk defa stanozolola bağlı kardiyovasküler yan 
etkilerin melatonin ile tedavisinin in vivo etkileri incelenmiştir. Stanozo-
lol bradikardiye neden olmuş ve önemli ölçüde kalp süperoksit dismu-
taz ve katalaz aktivitelerini arttırmıştır. Antrenmanlı olup stanozolol ile 
tedavi edilen sıçanlarda kan basıncı ve bağıl kalp ağırlığında bir artış göz-
lemlenmiş ve sol kalp aks sapması gelişmiştir. Melatonin uygulanması, 
stanozolol ile tedavi edilen hayvanlarda kalp hipertrofisine engel olama-
masına rağmen, kan basıncı ve kalp katalaz aktivitesini muhafaza etmiş 
ve stanozolola bağlı kalp elektrik aks sapmasını engellemeyi başarmıştır.
Sonuç: Sonuç olarak, deneysel koşullar altında, kronik stanozolol uygu-
lanması, melatonin tedavisi ile kısmen zayıflatılmış olan hafif kardiyovas-
küler yan etkilere neden olmaktadır. Ancak, bu sonuçlar melatonin ve 
egzersiz kombinasyonunun kardiyovasküler sistemde stanozololun yan 
etkilerini en aza indirelileceğini göstermektedir.
Anahtar Kelimeler: Stanozolol, Melatonin, Oksidatif stres, Anabolik et-
kileri, elektrokardiyogram, egzersiz
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Introduction
Stanozolol (STA) is a synthetic 17α-alkylated derivative 
of testosterone that exhibits a greater anabolic potency and 
a slower hepatic degradation than the natural male hor-
mone [1]. While endogenous steroids are essential for the 
homeostatic functions of the body, exogenous steroids, i.e., 
anabolic-androgenic steroids (AAS), can be used to increase 
muscle mass, reduce body fat, and improve patient response 
to major trauma or surgery. AAS are used to improve muscu-
lar dystrophy, treat HIV patients, treat osteoporosis, alleviate 
symptoms of depression and anemia and reduce the effects 
of male hypogonadism [2, 3]. 
In addition to their therapeutic use, AAS are employed 
at suprapharmacologic doses in the context of sports to 
increase muscular development, physical performance, aero-
bic capacity and tolerance to high-intensity training [1]. 
The growing number of recreational athletes using ASS for 
aesthetic purposes makes this a public health concern [4]. 
Its indiscriminate use can substantially affect the cardiac 
system by increasing the risk of cardiovascular events, such 
as arrhythmias, high blood pressure (BP), changes in plasma 
lipid concentrations (increased total cholesterol and LDL, 
decreased HDL), reduced blood clotting time, polycythemia, 
cardiac ischemia, thrombosis, myocardial infarction, left ven-
tricular hypertrophy and heart failure [3,5]. Moreover, many 
studies have shown a relationship between ASS abuse and 
disturbances in cardiac electrical impulse conduction, myo-
cardial apoptosis and sudden death [6-9]. 
In recent decades, sound evidence has been generated 
to show that oxidative stress is one of the most potent induc-
tors of endothelial dysfunction and cardiovascular disease. 
Contracting skeletal muscle, as well as cardiac muscle, gener-
ates increased amounts of reactive oxygen (ROS) and nitro-
gen species. ROS are byproducts of aerobic cellular metabo-
lism, and antioxidant enzymes such as superoxide dismutase 
(SOD) and catalase (CAT) play crucial roles in circumventing 
their deleterious effects [5]. 
Under normal physiological conditions, the majority of 
ROS are produced in the mitochondrial electron transport 
chain during oxygen’s reduction to water in the mitochondria 
[10]. Because the prolonged administration of STA provokes 
dysfunction of mitochondrial respiratory chain complexes 
and mono-oxygenase systems, it is possible for these altera-
tions to be accompanied by increased ROS generation [1, 11]. 
Melatonin (MEL), N-acetyl-5-methoxytryptamine, is the 
major hormone of the pineal gland, although it has also been 
detected in other tissues. It is a highly lipophilic molecule that 
crosses cell membranes easily to reach subcellular compart-
ments, including mitochondria, where it seems to accumulate 
in high concentrations. Melatonin is able to prevent oxidative 
stress both through its free radical scavenging effect and 
by directly increasing antioxidant activity, and studies have 
demonstrated its protective role against oxidative damage 
induced by drugs, toxins, and different diseases [12].
Because no information is available on the effects of 
17α-alkylated steroid treatment on cardiac antioxidant capac-
ity, we designed a study to investigate whether a prolonged 
treatment with high doses of STA modifies the activities of anti-
oxidant enzymes, such as catalase and superoxide dismutase, 
in the heart and whether this treatment causes alterations on 
cardiovascular parameters in sedentary and trained rats. MEL’s 
effectiveness as an antioxidant and modulator of cardiovascu-
lar side effects of STA treatment was also analyzed.
Materials and Methods
Training Protocol and Stanozolol and Melatonin
Treatment
Thirty male Wistar rats (10 weeks old, weighing approxi-
mately 300 g) were obtained from the animal facilities of the 
State University of Campinas. They were housed in collective 
cages at 22-24°C on a 12-h light-and-dark cycle, with free access 
to tap water and food (standard chow for rodents - Purina).
Rat care, handling, and all of the experimental procedures 
employed were in accordance with the Ethics Committee on 
Animal Experimentation of Unicamp. After the adaptation 
period (7 d), animals were randomly distributed among the 
following 6 groups: sedentary (S), stanozolol sedentary (SS), 
stanozolol-melatonin sedentary (SMS), trained (T), stanozolol 
trained (ST) and stanozolol-melatonin trained (SMT) (n = 5 for 
each group).
The T, ST and SMT groups were submitted to the swim-
ming protocol adapted from Radak et al. [13]. This protocol is 
an aerobic protocol without muscular damage, which could 
be induced by long-term running. The rats were submit-
ted to swimming exercise, 5 d.wk-1 for 6 wk, in a water tank 
(85x56x60 cm and water temperature at 31±1ºC). Exercise 
sessions were initiated between 10:00 and 11:00 a.m. All of 
the rats were adapted to the water during the first week of 
the experiment. The adaptation process consisted of keep-
ing the animals in shallow water, initially for 10 min and then 
progressively increasing 5 min/day and 5 cm water/day for 
7 days. Therefore, the rats became accustomed to the depth 
and effort. This process led to reduced stress without promot-
ing significant physical training adaptation. Exercise sessions 
began with 60 min/day during the second experimental 
week, and they were increased by 30 min each week until 
they reached 180 min of training during the sixth and last 
week of experiment. 
The clinical human STA (Zambon, Barcelona, Spain) dos-
age is 0.5 mg.kg-1.wk-1. The animals received 5 mg.kg-1 STA 
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by subcutaneous injection one hour before each exercise 
session (5 d.wk-1, i.e., 25 mg.kg1.wk-1); the CS and CT groups 
received only saline solution [3]. The high level of STA was 
chosen to simulate the massive doses of AAS used in sports.
The SMS and SMT rats received intraperitoneal injection of 
MEL (10 mg.kg-1), 5 d.wk-1 for 6 weeks. Injections were adminis-
tered at 10:00 a.m. (approximately 30 minutes before exercise 
session), while the other groups received only saline [14]. 
After the experimental period, the rats were sacrificed by 
deepening the anesthesia. Hearts were excised to determine 
relative weight and then rapidly frozen in nitrogen and stored 
at -80ºC for further analysis.
Electrocardiogram (ECG)
ECG was performed on each rat before and after the 
experiment periods. Anesthetized rats (ketamine and xyla-
zine, 90 mg/kg/bw and 45 mg/kg/bw, respectively, i.p.) were 
kept in the supine position with spontaneous breathing 
for ECG recording. The electrodes were connected to the 
computer channels (Heart Ware System), and six standard 
waves were recorded (I, II, III, aVR, aVR and aVF) with a sen-
sitivity of 2N at a speed of 50 mm/second. The QT interval 
was measured in ten consecutive beats from the beginning 
of the QRS-complex to the point of return of the T wave 
to the isoelectric line, defined as the TP segment. QTd was 
calculated in absolute values by subtracting the shortest QT 
interval from the longest (QTd = QT max – Qt min). This value 
was converted into a percentage (QTd%) by correcting the 
QTd for the shortest QT interval and multiplying this value by 
100 (QTd% = QT max – QT min/QT min x 100). The QT interval 
was corrected for the heart rate using Bazett’s formula (QTc = 
QT/√R-R), and the QTc interval dispersion was further calcu-
lated by subtracting the minimum QTc interval from the max-
imum QTc interval (QTcd = QTcmax - QTcmin). The percentage 
QTcd was also calculated (QTcd% = QTcmax - QTcmin/ QTcmin 
x 100). The analyses were conducted by a single observer 
blinded to the treatment the animals received to minimize 
divergences in the dispersion measurement [15].
Blood Pressure
To determine arterial systolic and diastolic blood pres-
sure, cannula were inserted into the left femoral artery and 
connected to BP-1-Analog single-channel transducer signal 
conditioner (World Precision Instruments, Sarasota, FL) [16].
Biochemical Assays
Heart samples were homogenized in an ice-cold isotonic 
0.01 mol/L sodium phosphate buffer (pH 7.4) and centrifuged 
for 5 minutes at 12,000xg at 4°C. Catalase activity was exam-
ined in the supernatant by the spectrophotometric method 
described by Cohen et al. [17]. Briefly, the catalase-catalyzed 
decomposition of H2O2 was determined by subjecting the 
samples to reaction for 3 minutes with a standard excess of 
KMnO4 and subsequent measurement of the residual KMnO4 
at 480 nm. Measurements were performed in triplicate. 
Protein concentrations were estimated by the bicinchoninic 
acid (BCA) method. Catalase activity was expressed as nM/µg 
protein content/min of the tissue homogenate for each group.
Superoxide dismutase activity was measured according 
to the method of Winterbourn et al. [18]. The principle of the 
assay was based on the ability of SOD to inhibit the reduction 
of nitro-blue tetrazolium (NBT). Briefly, the reaction mixture 
contained 2.7 mL of 0.067 M phosphate buffer (pH 7.8), 0.05 
mL of 0.12 mM riboflavin, 0.1 mL of 1.5 mM NBT, 0.05 mL of 
0.01 M methionine and 0.1 mL of enzyme samples. Uniform 
illumination of the tubes was ensured by an aluminum foil 
box under a 15 W fluorescent lamp for 10 min. A control 
without the enzyme source was included. The absorbance 
was measured at 560 nm. One unit of SOD was defined as 
the amount of enzyme required to inhibit the reduction of 
NBT by 50% under the specific conditions. The SOD activity 
was expressed as nM/µg protein/ min of tissue homogenate 
compared to the control group.
Statistical Analysis
Statistical differences were calculated by analysis of vari-
ance (ANOVA) and Tukey’s test to establish differences between 
groups. To compare variations inside the group between the 
beginning and end of the experiment, we used Student’s t-test 
implemented in Prism software (Graphpad Software Inc., USA). 
The results are reported as means±SD, and differences were 
considered to be significant when p<0.05.
Results
Heart Rate (HR) and body weight (BW)
BW gain was reduced in both exercise groups (T and ST 
groups) when compared to the sedentary group (S). The 
STA-treated group had decreased body weight gain when 
associated with melatonin and/or exercise protocol (SMS and 
SMT versus SS and ST, respectively) (Figure 1). There was no 
significant difference in HR between experimental groups at 
the beginning of the experiment (showing that the groups 
were homogeneous). Although there was also no significant 
difference in HR between experimental groups at the end of 
the experiment, there was a statistically significant difference 
when compared within the group itself (between baseline 
and the end of experimental period). All groups except for 
the sedentary group exhibited a reduction in recovery HR 
(Table 1).
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Arterial Blood Pressure (BP)
Figure 2 shows the results of systolic and diastolic blood 
pressures for all experimental groups. When associated with 
exercise (ST group), STA increased systolic and diastolic arte-
rial pressure; however, MEL administration maintained the BP 
(SMT group) similar to the control group.
Cardiovascular Parameters
Relative heart weight increased in the ST group when 
compared to the T group (Figure 3). MEL administration, 
despite preventing a raise in BP, did not prevent cardiac 
hypertrophy (SMT group). The ST group showed left cardiac 
electrical axis deviation (Table 2); however, the MEL-treated 
groups had no electrical axis deviation. There was no signifi-
cant difference in other electrocardiographic parameters.
Oxidative Stress Biomarkers
Figure 4 shows cardiac SOD and CAT activity values after 
the experimental protocol. Our results showed that all STA-
treated groups had higher SOD activity than in the S group. 
Similarly, the trained groups showed increased heart SDO 
activity when compared to the control group. The cardiac 
catalase activity also increased in the STA-treated groups (SS 
and ST groups). MEL administration prevented the increase of 
cardiac CAT activity but had no effect on cardiac SOD activity.
Discussion
Our study showed that prolonged (6 wk) MEL administra-
tion partly attenuated STA-induced cardiac side effects. This 
finding has great clinical relevance because AAS use (both 
clinical and ergogenic) has been increasing significantly 
over recent decades, and its side effects can be considered 
a public health concern [4]. Furthermore, our results showed 
that exercise combined with STA administration can have 
worse effects on cardiac tissue, and when associated with 
melatonin, these side effects can be minimized. This study 
was the first time that the in vivo effects of MEL treatment on 
STA-induced cardiovascular side effects have been studied. 
STA treatment alone (SS group) did not change body 
weight, while MEL treatment decreased weight gain in sed-
entary rats treated with STA (SMS group). This result is in 
agreement with Wolden-Hanson et al. [19]. The authors 
Figure 1. Effects of stanozolol treatment, melatonin treatment and/or 
exercise training on body weight variation of Wistar rats in the sedentary 
(S), stanozolol sedentary (SS), stanozolol-melatonin sedentary (SMS), 
trained (T), stanozolol trained (ST) and stanozolol-melatonin trained 
(SMT) groups. The results are expressed as means±standard deviation; P 
<0.05 for (b) S x T, (c) SS x SMS. 
Figure 2. Systolic and diastolic arterial pressures of Wistar rats in the sedentary (S), stanozolol sedentary (SS), stanozolol-melatonin sedentary (SMS), 
trained (T), stanozolol trained (ST) and stanozolol-melatonin trained (SMT) groups. The results are expressed as means ± standard deviation; P <0.05 
for (d) T x ST; (e) ST x SMT. 
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demonstrated in rats that 12 weeks of MEL treatment without 
associated changes in food consumption decreased BW, rela-
tive intra-abdominal adiposity and plasma leptin and insulin 
levels while increasing spontaneous physical activity, body 
temperature and basal plasma corticosterone content toward 
youthful levels.
The verification of resting bradycardia in the exercise 
group (T group) demonstrated the effectiveness of the train-
ing protocol proposed in this study. Resting bradycardia has 
been considered to be the hallmark of the cardiovascular 
effect of exercise-training adaptation in both animals and 
humans [20].
Meanwhile, the STA treatment alone reduced the HR. This 
result is in agreement with the previous report of Beutel, 
Bergamaschi & Campos [3], who showed resting bradycar-
dia in rats treated with STA. El-Mas et al. [21] showed that 
testosterone can act on the brainstem and preganglionic 
vagal cardiomotor neurons, modulating the autonomic car-
diac control. Here, we also showed that STA promoted 
the increase of relative heart weight when combined with 
exercise, without changing the body weight gain. Our result 
is in agreement with Du Toit et al. [7], who also observed 
increased relative heart weight in rats submitted to exercise 
and AAS treatment. Many studies have shown that AAS 
may act on cardiomyocytes, leading to cardiac hypertrophy 
[3, 8]. Moreover, AAS abuse has been related to sometimes 
irreversible cardiomyocyte changes, such as concentric left 
ventricular hypertrophy [3, 6]. AAS anabolic effect is mainly 
mediated through androgenic receptors present in large 
amounts in skeletal and cardiac muscles. These androgenic 
receptors regulate transcription of target-genes promoting 
the accumulation of DNA required for muscle growth [22]. 
In our experiment, relative heart weight was significantly 
increased only in rats treated with STA and submitted to the 
exercise protocol (ST group). Both resistance training and 
long-term AAS exposure can enhance androgenic recep-
tor content [23, 24]. This phenomenon would be a possible 
mechanism by which high doses of AAS, combined with 
exercise, could lead to cardiac hypertrophy [8]. Another fac-
tor of great importance regarding cardiac hypertrophy is 
collagen fiber content. Both STA and exercise can stimulate 
collagen synthesis in cardiac muscle, and the combination of 
these two factors could significantly increase the heart’s col-
lagen content. Chronic AAS abuse, alone or combined with 
exercise, might promote pathological cardiac hypertrophy 
with cardiac function loss [7]. STA seems to stimulate collagen 
synthesis, due in large part to TGF- β1 (transforming growth 
factor- β1) action. This protein is a potent collagen stimulator 
that is normally secreted in the acute phase of inflammation 
and acts on tissue repair [2, 25]. 
STA promoted left axis deviation in the ST group; how-
ever, this deviation was within the normal range expected for 
Table 1. Heart rates of Wistar rats in the sedentary (S), stanozolol 
sedentary (SS), stanozolol-melatonin sedentary (SMS), trained 
(T), stanozolol trained (ST) and stanozolol-melatonin trained 
(SMT) groups, before the beginning of the experiment and after. 
The results are expressed as means±standard deviation. 
Group Before After
S 458.6±7.4 449.8±10.0
SS 449.3±13.9 406.3±4.1*
SMS 458.3±2.7 410.5±5.0*
T 466.3±5.1 417.5±10.2*
ST 467.8± 4.8 394.0±4.9*
SMT 461.0±13.3 376.3±12.5*
*P<0.05, significantly different from pretreatment values.
Table 2. Cardiac axis deviations (º) of Wistar rats in the sedentary 
(S), stanozolol sedentary (SS), stanozolol-melatonin sedentary 
(SMS), trained (T), stanozolol trained (ST) and stanozolol-melato-
nin trained (SMT) groups, before the beginning of the experiment 
and after. The results are expressed as means±standard deviation. 
Group Before After
S 50.00±9.35 58.75±5.15 
SS 60.00±5.00 56.67±7.26
SMS 52.50±4.79 56.00±3.08
T 54.17±2.71 60.33±1.33
ST 63.75±3.15 50.00±2.04*
SMT 57.50±3.23 55.00±4.56
*P<0.05, significantly different from pretreatment values.
Figure 3. Relative heart weights of Wistar rats in the sedentary (S), stanozo-
lol sedentary (SS), stanozolol-melatonin sedentary (SMS), trained (T), stano-
zolol trained (ST) and stanozolol-melatonin trained (SMT) groups. The 
results are expressed as means±standard deviation; P <0.05 for (d) T x ST. 
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rats. This result might be due to the increase in relative heart 
weight and cardiomyocyte area (data not shown). The mean 
cardiac axis represents the net direction and magnitude of 
cardiac electrical force. In essence, the QRS electrical axis is 
useful because it helps to determine the position of the heart 
in the chest, patency of electrical pathways and integrity of 
muscle mass. Despite some criticisms, a number of studies 
suggest that morphological aspect analysis of the electrical 
axis (amplitude and duration changes by ECG) is one of the 
primary tools to detect ventricular hypertrophy and sudden 
cardiac death [26]. QRS duration is frequently increased in left 
ventricular hypertrophy. The increased QRS duration might 
be attributed to the increased thickness of the left ventricle 
wall and to intramural fibrosis, which distorts and prolongs 
the transmural impulse propagation. Prolongation of the 
QT interval is indicative of potential risk of lethal arrhythmia 
and cardiac sudden death [27]. In our results, there was no 
difference in QRS, QT and QTc duration among experimental 
groups; hence, ventricular activation has not been impaired 
by STA treatment. Thus, the fact that duration of QT and 
QTc intervals have been presented with no changes among 
the experimental groups corroborates the values found for 
QRS, discarding the risk of sudden death (as verified in our 
experimental conditions) as suggested in previous studies as 
a consequence of AAS abuse [9, 28].
The lack of hypotension response in the exercise group 
is consistent with Medeiros [20], who reported no significant 
BP decrease in normotensive rats submitted to swimming 
training. In fact, exercise training has been recommended as 
a non-pharmacological treatment for high BP, but its effect in 
normotensive animals and humans seems to be minimal [29]. 
MEL was efficient for preventing BP elevation in exercised rats 
submitted to STA treatment (SMT group). MEL administra-
tion has been related to BP lowering due to several mecha-
nisms, such as direct hypothalamic effect, catecholamine 
level reduction, smooth muscle relaxation and the antioxi-
dant properties of MEL [30]. Spontaneously hypertensive rats 
submitted to MEL treatment experienced HR and BP reduc-
tion due to increased endothelium-dependent vasodilatation 
[31]. Moreover, BP decrease and baroreflex improvement in 
spontaneously hypertensive rats are related to long-term 
MEL treatment due to its antioxidant properties and decrease 
in the sympathetic drive [31]. Indeed, MEL-induced oxidative 
stress reduction might have contributed to HR and BP modu-
lation, as we verified in the SMT group. MEL administration 
did not prevent cardiac hypertrophy in exercised animals 
treated with STA (SMT group); however, it prevented electrical 
axis deviation in this group. This result is in agreement with 
Simko et al. [31], who also observed that MEL did not reverse 
left ventricular hypertrophy in hypertensive rats, although 
fibrosis was reduced in hypertrophied ventricles (the authors 
also attributed this recution to its antioxidant properties, 
inhibiting the inflammatory process). It is known that NO and 
free radical availability might be involved in cardiac remodel-
ing [30]. In a study with pinealectomized rats with a signifi-
cant decrease in MEL secretion, Paulis & Simko [26] showed 
an increase in heart weight and cardiac fibrosis. 
Another way to assess myocardial damage is to determine 
the effects of exercise and/or any treatment on the antioxi-
dant system, which might be reflected by a high or low rate 
of ROS production during exercise in response to oxidative 
stress [27]. Intense and/or prolonged exercise sessions can 
cause oxidative stress in the heart; therefore, repetition of 
the exercise stimulus throughout the training period could 
Figure 4. Cardiac SOD and CAT activities of Wistar rats in the sedentary (S), stanozolol sedentary (SS), stanozolol-melatonin sedentary (SMS), trained 
(T), stanozolol trained (ST) and stanozolol-melatonin trained (SMT) groups. The results are expressed as means ± standard deviation; P <0.05 for (a) S 
x SS; (b) S x T, (c) SS x SMS; (d) T x ST; (e) ST x SMT. 
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activate the synthesis of antioxidant enzymes as a long-term 
strategy to cope with the oxidative stress encountered dur-
ing exercise sessions [1]. The heart is equipped with all of the 
major antioxidant enzymes, i.e., SOD, CAT and glutathione 
peroxidase (GPx), as well as adequate levels of glutathi-
one reductase (GRD) and glutathione S-transferases (GST). 
Regular physical exercise might beneficially influence cardiac 
antioxidant defenses and promote overall cardiac function. 
Several lines of evidence suggest that exercise induces adap-
tations in many tissues against an oxidative insult, mainly due 
to a mild oxidative stress, which could upregulate antioxidant 
enzyme gene expression through redox-regulated transcrip-
tion factors [5]. In our experiment, swimming training and 
STA administration, alone or combined, increased cardiac 
SOD activity. MEL treatment did not prevent this enhanced 
activity. These results are in agreement with several studies 
showing that regular physical activity increases SOD activ-
ity in cardiac and skeletal muscle [5, 27]. On the other hand, 
Souza-Rabbo et al. [28] found decreased SOD activity in 
the heart after thirteen weeks of treadmill training in rats. 
According to Berra & Rizzo [29], MEL increases SOD activity, 
but this effect did not occur in our study. This different can be 
explained because, in our experiment, the rats were treated 
with MEL and also with STA, which is known to promote an 
increase in SOD activity. In addition, MEL also has direct anti-
oxidant effects, which could lead to a decrease in ROS. This 
reduction in ROS generation could maintain or even reduce 
SOD activity.
Other studies have shown contradictory results related to 
the effect of exercise on the CAT enzyme. There are studies 
showing increase [30], no change [5], or decrease [27] in CAT 
activity after exercise. Exercise intensity and the moment that 
antioxidant enzyme activity analysis is performed after the 
last exercise session seem to be the key factors in revealing 
detectable effects of ROS on antioxidant enzyme activities in 
rodent hearts [30]. 
Training protocol alone did not change cardiac CAT activ-
ity, while STA induced elevation of cardiac CAT activity; this 
elevation was prevented by MEL administration. These results 
contradict those shown by Chaves et al. [5], who found no 
significant difference in cardiac CAT activity in rats treated 
with the AAS nandrolone decanoate when compared to the 
control group. In addition, Tomás-Zapico & Coto-Montes 
[31] showed an increase in CAT activity after treatment with 
MEL, while our study showed a decrease in CAT activity after 
treatment with MEL. We believe that the increase in CAT activ-
ity, or any other antioxidant enzymes, due to MEL-induced 
antioxidant enzyme activity does not occur in an environ-
ment where oxidative stress (and the changes induced by 
it) is already applied. Thus, the direct antioxidant effect of 
MEL would lead to decreased oxidative stress, consequently 
lowering antioxidant enzyme activity. Most of these studies 
did not use an exercise protocol, which obviously influences 
the responses of antioxidant enzyme activities.
In conclusion, the chronic use of supraphysiological doses 
of STA induced bradycardia and increased cardiac SOD 
and CAT activities. STA combined with swimming led to an 
increase in systolic and diastolic blood pressure, relative heart 
weight and left cardiac axis deviation. Although MEL did not 
prevent cardiac hypertrophy in exercised animals treated 
with STA, it prevented blood pressure elevation and the 
increase of cardiac catalase activity. MEL also prevented the 
STA-induced electric cardiac axis deviation. Hence, under our 
experimental conditions, the adverse effects of STA on the 
cardiovascular system were partly attenuated by MEL treat-
ment. New experiments are now underway in our laboratory 
to investigate how MEL treatment could improve and mini-
mize the side effects produced in the cardiovascular system.
by STA administration.
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